On Monday, Glaukos Corporation (NYSE:GKOS) received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application (NDA) for ...

Please provide your email address to receive an email when new articles are posted on . Patients who underwent cross-linking were younger and white and had commercial insurance. Patients treated with ...

Keratoconus is a progressive eye condition that affects the shape and clarity of the cornea, often beginning in the teenage years or early adulthood. As the cornea thins and bulges into a cone-like ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Keratoconus is an eye condition that affects the cornea, the transparent outer layer of the eye. Instead of maintaining its usual dome shape, the cornea begins to thin and bulge outward, forming a ...

Please provide your email address to receive an email when new articles are posted on . Modern technologies suggest that detection of keratoconus was previously underestimated. A global map of ...

If things went wrong, the stem cells could turn into other cells - like for hair or teeth - instead of eyes.